Prognostic role of the MRI-based involvement of superior pharyngeal constrictor muscle in oropharyngeal squamous cell carcinoma.

HPV squamous cell carcinoma superior pharyngeal constrictor muscle surgery survival

Journal

Head & neck
ISSN: 1097-0347
Titre abrégé: Head Neck
Pays: United States
ID NLM: 8902541

Informations de publication

Date de publication:
Jan 2024
Historique:
revised: 23 08 2023
received: 11 04 2023
accepted: 22 10 2023
pubmed: 1 11 2023
medline: 1 11 2023
entrez: 1 11 2023
Statut: ppublish

Résumé

The aim of this study was to determine the impact of the involvement of the superior pharyngeal constrictor muscle (SPCM) evaluated by magnetic resonance imaging (MRI) on outcome in oropharyngeal squamous cell carcinomas (OPSCCs). A retrospective study including consecutive patients with OPSCC treated with curative intent. A total of 82 consecutive patients with OPSCC met inclusion criteria. At multivariate analysis, patients with SPCM infiltration were at significantly higher risk of death (HR: 3.37, CI: 1.21-9.38) and progression (HR: 3.39, CI: 1.38-8.32). In a multivariate model conditioned on HPV status, a significantly higher risk of death and progression was observed by combining both SPCM and HPV status with patients harboring an HPV-negative OPSCC with SPCM infiltration showing the poorest outcome. MRI evidence of SPCM involvement significantly and independently increases the risk of death and progression in subjects with OPSCC. Considering both MRI-assessed SPCM infiltration and HPV status significantly improved risk stratification in these malignancies.

Identifiants

pubmed: 37909147
doi: 10.1002/hed.27566
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

161-170

Informations de copyright

© 2023 The Authors. Head & Neck published by Wiley Periodicals LLC.

Références

Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-249. doi:10.3322/caac.21660
Boscolo-Rizzo P, Dietz A. The AJCC/UICC eighth edition for staging head and neck cancers: Is it wise to de-escalate treatment regimens in p16-positive oropharyngeal cancer patients? Int J Cancer. 2017;141(7):1490-1491. doi:10.1002/ijc.30837
Klussmann JP, Gultekin E, Weissenborn SJ, et al. Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus. Am J Pathol. 2003;162(3):747-753.
Grønhøj C, Jakobsen KK, Jensen DH, et al. Pattern of and survival following loco-regional and distant recurrence in patients with HPV+ and HPV-oropharyngeal squamous cell carcinoma: a population-based study. Oral Oncol. 2018;83:127-133. doi:10.1016/j.oraloncology.2018.06.012
Strohl MP, Wai KC, Ha PK. De-intensification strategies in HPV-related oropharyngeal squamous cell carcinoma-a narrative review. Ann Transl Med. 2020;8(23):1601. doi:10.21037/atm-20-2984
Laccourreye O, Hans S, Ménard M, Garcia D, Brasnu D, Holsinger FC. Transoral lateral oropharyngectomy for squamous cell carcinoma of the tonsillar region: II. An analysis of the incidence, related variables, and consequences of local recurrence. Arch Otolaryngol Head Neck Surg. 2005;131(7):592-599. doi:10.1001/archotol.131.7.592
Baskin RM, Boyce BJ, Amdur R, et al. Transoral robotic surgery for oropharyngeal cancer: patient selection and special considerations. Cancer Manag Res. 2018;10:839-846. doi:10.2147/CMAR.S118891
Gorphe P. A contemporary review of evidence for transoral robotic surgery in laryngeal cancer. Front Oncol. 2018;8:121. doi:10.3389/fonc.2018.00121
Tirelli G, Boscolo Nata F, Piovesana M, Quatela E, Gardenal N, Hayden RE. Transoral surgery (TOS) in oropharyngeal cancer: different tools, a single mini-invasive philosophy. Surg Oncol. 2018;27(4):643-649. doi:10.1016/j.suronc.2018.08.003
Gardenal N, Rigo S, Boscolo Nata F, et al. The CO2 waveguide laser with flexible fiber in transoral resection of oral and oropharyngeal cancers: a retrospective cohort study on postoperative and quality of life outcomes. Lasers Med Sci. 2022;37(3):1755-1762. doi:10.1007/s10103-021-03430-x
Caudell JJ, Gillison ML, Maghami E, et al. NCCN guidelines® insights: head and neck cancers, version 1.2022. J Natl Compr Cancer Netw. 2022;20(3):224-234. doi:10.6004/jnccn.2022.0016
Ng SH, Yen TC, Liao CT, et al. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation. J Nucl Med. 2005;46(7):1136-1143.
Dequanter D, Shahla M, Aubert C, Deniz Y, Lothaire P. Prognostic value of FDG PET/CT in head and neck squamous cell carcinomas. OncoTargets Ther. 2015;8:2279-2283. doi:10.2147/OTT.S85479
Mena M, Taberna M, Tous S, et al. Double positivity for HPV-DNA/p16ink4a is the biomarker with strongest diagnostic accuracy and prognostic value for human papillomavirus related oropharyngeal cancer patients. Oral Oncol. 2018;78:137-144. doi:10.1016/j.oraloncology.2018.01.010
Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data: Kalbfleisch/The Statistical. John Wiley & Sons; 2002. doi:10.1002/9781118032985
Jd A, Me K, Km H. Radical tonsillectomy and superior pharyngeal constrictor anatomy: a cadaveric and oncologic specimen assessment. J Oto-Rhino-Laryngol Head Neck Surg. 2020;82(6):318-326. doi:10.1159/000508136
De Virgilio A, Kim SH, Magnuson JS, et al. Anatomical-based classification for transoral lateral oropharyngectomy. Oral Oncol. 2019;99:104450. doi:10.1016/j.oraloncology.2019.104450
Park JO, Lee YS, Joo YH, Nam IC, Cho KJ, Kim MS. Can the transoral approach secure a cancer-free deep margin in tonsil cancer? Oral Oncol. 2012;48(7):658-661. doi:10.1016/j.oraloncology.2012.01.009
Park JO, Lee YS, Joo YH, et al. Significant invasion of the pharyngeal constrictor muscle in early squamous cell carcinoma of the tonsil: prediction of multiple regional metastasis. Arch Otolaryngol Head Neck Surg. 2012;138(11):1034-1039. doi:10.1001/2013.jamaoto.467
Boscolo-Rizzo P, Mistro AD, Bussu F, et al. New insights into human papillomavirus-associated head and neck squamous cell carcinoma. Acta Otorhinolaryngol Ital. 2013;33(2):77-87.
Schroeder L, Boscolo-Rizzo P, Dal Cin E, et al. Human papillomavirus as prognostic marker with rising prevalence in neck squamous cell carcinoma of unknown primary: a retrospective multicentre study. Eur J Cancer Oxf Engl. 1990;2017(74):73-81. doi:10.1016/j.ejca.2016.12.020
Boscolo-Rizzo P, Schroeder L, Romeo S, Pawlita M. The prevalence of human papillomavirus in squamous cell carcinoma of unknown primary site metastatic to neck lymph nodes: a systematic review. Clin Exp Metastasis. 2015;32(8):835-845. doi:10.1007/s10585-015-9744-z
Westra WH. The morphologic profile of HPV-related head and neck squamous carcinoma: implications for diagnosis, prognosis, and clinical management. Head Neck Pathol. 2012;6(Suppl 1):S48-S54.
Chernock RD, Nussenbaum B, Thorstad WL, et al. Extensive HPV-related carcinoma in situ of the upper aerodigestive tract with “nonkeratinizing” histologic features. Head Neck Pathol. 2013;8(3):322-328. doi:10.1007/s12105-013-0499-z
Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363(1):24-35.
Boscolo-Rizzo P, Pawlita M, Holzinger D. From HPV-positive towards HPV-driven oropharyngeal squamous cell carcinomas. Cancer Treat Rev. 2016;42:24-29. doi:10.1016/j.ctrv.2015.10.009
International Consortium for Outcome Research (ICOR) in Head and Neck Cancer, Ebrahimi A, Gil Z, et al. Primary tumor staging for oral cancer and a proposed modification incorporating depth of invasion: an international multicenter retrospective study. JAMA Otolaryngol Head Neck Surg. 2014;140(12):1138-1148. doi:10.1001/jamaoto.2014.1548
Mücke T, Kanatas A, Ritschl LM, et al. Tumor thickness and risk of lymph node metastasis in patients with squamous cell carcinoma of the tongue. Oral Oncol. 2016;53:80-84. doi:10.1016/j.oraloncology.2015.11.010
Tirelli G, Zacchigna S, Boscolo Nata F, Quatela E, Di Lenarda R, Piovesana M. Will the mininvasive approach challenge the old paradigms in oral cancer surgery? Eur Arch Oto-Rhino-Laryngol Head Neck Surg. 2017;274(3):1279-1289. doi:10.1007/s00405-016-4221-0
Tirelli G, Piccinato A, Antonucci P, Gatto A, Marcuzzo AV, Tofanelli M. Surgical resection of oral cancer: en-bloc versus discontinuous approach. Eur Arch Oto-Rhino-Laryngol Head Neck Surg. 2020;277(11):3127-3135. doi:10.1007/s00405-020-06016-5
Yumii K, Ueda T, Urabe Y, et al. Determining invasion depth in superficial pharyngeal carcinoma by transoral ultrasonography. Laryngoscope. 2022;28:2192-2197. doi:10.1002/lary.30483
Kim YJ, Jeong WJ, Bae YJ, et al. MRI-based assessment of the pharyngeal constrictor muscle as a predictor of surgical margin after transoral robotic surgery in HPV-positive tonsillar cancer. AJNR Am J Neuroradiol. 2020;41(12):2320-2326. doi:10.3174/ajnr.A6806
Jc J, Ka S, Cm G. Imaging of head and neck cancer with CT, MRI, and US. Semin Nucl Med. 2021;51(1):3-12. doi:10.1053/j.semnuclmed.2020.07.005
Dal Cin E, Marcuzzo AV, Degrassi F, et al. HPV impact on oropharyngeal cancer radiological staging: 7th vs 8th edition of AJCC TNM classification. Clin Imaging. 2022;93:39-45. doi:10.1016/j.clinimag.2022.10.010
Zhou J, Schwenk-Zieger S, Kranz G, et al. Isolation and characterization of head and neck cancer-derived peritumoral and cancer-associated fibroblasts. Front Oncol. 2022;12:984138.

Auteurs

Giancarlo Tirelli (G)

Department of Medical, Surgical and Health Sciences, Section of Otolaryngology, University of Trieste, Trieste, Italy.

Alberto Vito Marcuzzo (AV)

Department of Medical, Surgical and Health Sciences, Section of Otolaryngology, University of Trieste, Trieste, Italy.

Nicoletta Gardenal (N)

Department of Medical, Surgical and Health Sciences, Section of Otolaryngology, University of Trieste, Trieste, Italy.

Margherita Tofanelli (M)

Department of Medical, Surgical and Health Sciences, Section of Otolaryngology, University of Trieste, Trieste, Italy.

Ferruccio Degrassi (F)

Department of Medical, Surgical and Health Sciences, Section of Radiology, University of Trieste, Trieste, Italy.

Maria Assunta Cova (MA)

Department of Medical, Surgical and Health Sciences, Section of Radiology, University of Trieste, Trieste, Italy.

Erika Sacchet (E)

Department of Medical, Surgical and Health Sciences, Section of Otolaryngology, University of Trieste, Trieste, Italy.

Fabiola Giudici (F)

Unit of Cancer Epidemiology, Centro di Riferimento Oncologico di Aviano (CRO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Aviano, Italy.

Jerry Polesel (J)

Unit of Cancer Epidemiology, Centro di Riferimento Oncologico di Aviano (CRO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Aviano, Italy.

Paolo Boscolo-Rizzo (P)

Department of Medical, Surgical and Health Sciences, Section of Otolaryngology, University of Trieste, Trieste, Italy.

Classifications MeSH